Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Clinical Trial Coverage For IND-Exempt Trials Sought By PhRMA

Executive Summary

PhRMA is urging the Health Care Financing Administration to include permanent automatic qualification for IND-exempt trials in its Medicare clinical trial coverage policy.
Advertisement

Related Content

Formulary Cost-Sharing In Patients' Rights Bill Likely Awaits Conference Cmte
Formulary Cost-Sharing In Patients' Rights Bill Likely Awaits Conference Cmte
Clinical Trials Need Peer Review To Qualify For Medicare Funds - AHRQ Panel
Clinical Trials Need Peer Review To Qualify For Medicare Funds - AHRQ Panel
Clinical Rx Trials Could Gain HCFA Financial Support Under Clinton Directive
Clinical Rx Trials Could Gain HCFA Financial Support Under Clinton Directive
Advertisement
UsernamePublicRestriction

Register

PS036822

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel